News
The QbD Group acquires Turnstone Communications and BioVox to strengthen its specialist science communication and marketing services
Wilrijk/Ghent, Belgium, 25 May 2023 – The QbD Group, a privately held company offering comprehensive support to life science companies […] May 25, 2023 · Turnstone Communications
Article
OHMX.bio: state-of-the-art omics solutions
OHMX.bio provides innovative omics solutions using state-of-the-art sequencing and mass spectrometry platforms. Specializing in expression analysis (RNA-seq and RIBO-seq) and […] May 24, 2023 · MEDVIA
Article
Fake it till you fund it?
Silicon Valley investment gurus have long promoted the idea that startups should ‘fake it till you make it’ to become […] May 24, 2023 · V-Bio Ventures
Article
Unlocking the potential of patient data using healthcare data standards
May 24, 2023 · Janssen PharmaceuticaV-Bio Ventures portfolio company Dualyx raises €40 million to progress Treg therapies for autoimmune diseases into the clinic
Use of proceeds will enable the development of the Company’s lead autoimmune program DT-001, targeting TNFR2, as well as its […] May 15, 2023 · V-Bio Ventures
Article
Corteria: a new strategy and approach to treating heart failure
Corteria Pharmaceuticals is developing transformative therapies for heart failure subpopulations most likely to benefit from the company’s novel cardiorenal treatments. […] April 25, 2023 · V-Bio Ventures
Article